Jane Henderson

Jane Henderson has an estimated net worth of $18.4 Million. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., Voyager Therapeutics, Inc., Akero Therapeutics, Inc., IVERIC bio, Inc., Sesen Bio, Inc., PANACOS PHARMACEUTICALS, INC., Apogee Therapeutics, Inc., and CARGO Therapeutics, Inc..

2018 was Jane Henderson's most active year for acquiring shares with 8 total transactions. Jane Henderson's most active month to acquire stocks was the month of May. 2026 was Jane Henderson's most active year for disposing of shares, totalling 17 transactions. Jane Henderson's most active month to dispose stocks was the month of February. 2023 saw Jane Henderson paying a total of $280,400.00 for 252,433 shares, this is the most they've acquired in one year. In 2023 Jane Henderson cashed out on 242,862 shares for a total of $2,166,684.66, their largest year based on trade value.